End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
745,000 KRW | -1.32% | -5.70% | -1.97% |
May. 23 | US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz | MT |
May. 06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 781,000.00 | 859,000.00 | 859,000.00 |
Spread/Res. | -4.61% | -13.27% | -13.27% |
Spread/Supp. | -0.80% | +6.73% | +9.40% |
Support | 751,000.00 | 698,000.00 | 681,000.00 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- A207940 Stock
- Charts Samsung Biologics Co.,Ltd.